Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail
-

Public Calendar for Nov. 26-30

 

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and Title Date Location Other FDA Participants Non-FDA Participants Subject
Andrew von Eschenbach, Commissioner, Food and Drugs 11/27/07 Silver Spring, MD Stephen Mason, Deborah Autor, Jeremiah Kelly, Jennifer Divine, Mike Levy U.S. Representative Marion Berry, U.S. Representative Mike Ross, Bob Russell (Office of U.S. Senator Pryor) Unapproved Hydrocodone products
Andrew von Eschenbach, Commissioner, Food and Drugs 11/28/07 Atlanta, GA Randall Lutter, Faye Feldstein, Jesse Goodman, Boris Lushniak, Robert Ali, Irene Chan, Morris Potter, Steve Solomin N/A Center for Disease Control/FDA Leadership Forum
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer 11/26/07 through 11/30/07 N/A N/A N/A No significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs 11/28/07 Brussels, Belgium Justina Molzon, Michelle Limoli, Nicholas Buhay, Joan Blair Representatives of U.S. and European Union (EU) industry group, and regulators from the EU, European Commission, and the European Medicines Agency Administrative Simplification Workshop
Murray Lumpkin, Deputy Commissioner for International and Special Programs 11/29/07 London, England N/A Members of the Royal College of Pharmaceutical Medicine Speech at the  Annual Meeting of the Royal College of Pharmaceutical Physicians on U.S. Pediatric Initiatives
Murray Lumpkin, Deputy Commissioner for International and Special Programs 11/30/07 London, England N/A Sir Alasdair Breckenridge (Medicines and Healthcare products Regulatory Agency), Ragnar Löfstedt (The King's Centre for Risk Management at the University of London) Risk management tools and possibilities
Randall Lutter, Deputy Commissioner for Policy  11/27/07 Washington, DC Malcolm Bertoni, Irene Chan National Academy of Sciences members Risk ranking project
Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs, Chief Medical Officer and Acting Director, Center for Drug Evaluation and Research  1/29/07 Bangkok, Thailand  N/A  N/A Speech on Personalized Medicine at The Sixth Princess Chulabhorn International Science Congress
Margaret Glavin, Associate Commissioner, Office of Regulatory Affairs 11/26/07 through 11/30/07 N/A N/A N/A No significant meetings
Jesse Goodman, Director, Center for Biologics Evaluation and Research 11/26/07 through 11/30/07 N/A N/A N/A No significant meetings
Daniel Schultz, Director, Center for Devices and Radiological Health 11/28/07 Rockville, MD Jeffrey Senger Eamonn Hobbs (AngioDynamics).  Jodie Low and Jeffrey Kimbell (Jeffrey J. Kimbell & Associates) Device issues
David Acheson, Acting Director, Center for Food Safety and Applied Nutrition 11/26/07 through 11/30/07 N/A N/A N/A No significant meetings
Stephen Sundlof, Director, Center for Veterinary Medicine 11/28/07 Rockville, MD Bernadette Dunham, William Flynn, Martine Hartogensis, Sharon Benz, Lynn Post Bill Bookout and Dale Metz (National Animal Supplement Council) Meet and greet
Stephen Sundlof, Director, Center for Veterinary Medicine 11/30/07 Rockville, MD Merton Smith, Shannon Jordre, Burt Pritchett Yoichi Watanabe and Noboru Kawamoto (Embassy of Japan) Update on Feed Ban rule.
William Slikker, Director, National Center for Toxicological Research 11/26/07 through 11/30/07 N/A N/A N/A No significant meetings
Gerald Masoudi, Chief Counsel 11/26/07 Rockville, MD Jeff Senger, Ann Wion, Laura Epstein Nancy Cahill (Aim Group), Randy Scott and Kim Popovits (Genomic Health), Paul Thompson and Paul Radensky (McDermott, Will & Emory), Jeffrey Gibbs (Hyman, Phelps, McNamara) Genomic Health, Inc.'s In Vitro Diagnostic Multivariate Index Assays (IVDMIA) document
Gerald Masoudi, Chief Counsel 11/27/07 Washington, DC Jeff Senger, Scott, Danzis Pharmaceutical Research and Manufacturers of America (PhRMA)  members Regulatory Issues

 

-
-